Install
Houston Community College and UH Downtown
Houston Community College and UH Downtown: campus news, research, athletics and the people there.
- 7 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Houston Community College and UH Downtown
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
1+ day, 18+ hour ago (207+ words) Investing News Network Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026 Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced…...
Immune Booster Cells Show Promise After Checkpoint Blockers in Liver Cancer
1+ day, 23+ hour ago (723+ words) Bioengineer.org...
Immunotherapy Breakthroughs and Single-Cell Atlas Studies Reshape Liver Cancer Care in China
2+ day, 16+ hour ago (67+ words) Bioengineer.org Subject of Research: Clinical trials and basic research advances in hepatocellular carcinoma immunotherapy and tumor biology in China Article Title: Advances in clinical and basic research for hepatocellular carcinoma in China: a 2023 review News Source: Nathaniel Bowman. (October…...
Global Survey Reveals Wide Gap Between Liver Cancer Guidelines and
3+ day, 20+ hour ago (28+ words) Real-World Practice Bioengineer.org Article Title: Think tank on locoregional treatments in hepatocellular carcinoma: a snapshot of real-life practice...
Validation of the Up7-ALBI Score for Prognostication in Unresectable H | JHC | Dove Medical Press
4+ day, 8+ hour ago (1236+ words) Dove Medical Press is a member of the OAI. Bulk reprints for the pharmaceutical industry. We offer real benefits to our authors, including fast-track processing of papers. Back to Journals » Journal of Hepatocellular Carcinoma » Volume 13 Authors Lu CH, Kao WY,…...
How Immunotherapy Is Rewriting the Rules of Liver Cancer Treatment
5+ day, 9+ hour ago (55+ words) Liver cancer has long been one of the most stubborn enemies in oncology, and hepatocellular carcinoma, which accounts for more than 90 percent of primary liver cancers, sits at the center of that fight. According to World Health Organization data from…...
Liquid Embolic Turns Liver Cancer Emergencies into Curable Cases
5+ day, 11+ hour ago (55+ words) When a liver tumor bursts, the clock starts ticking in minutes. Ruptured hepatocellular carcinoma, the most common primary liver cancer, is one of the most dramatic emergencies in hepatology: blood pours into the abdominal cavity, blood pressure collapses, and historically…...
Four Metabolic Genes Predict Survival in Aggressive Liver Cancer
6+ day, 1+ hour ago (55+ words) Intrahepatic cholangiocarcinoma, the second most common primary malignant tumor of the liver, is one of oncology’s most formidable adversaries. Its incidence has surged by 140 percent over the past decade, yet the five-year overall survival rate remains stubbornly below 10 percent. Surgery…...
Rznomics Receives Positive Opinion for Orphan Medicinal Product Designation of RZ-001 for Glioma
1+ week, 1+ hour ago (406+ words) SEONGNAM, South Korea, Sept. 30, 2026 /PRNewswire/ -- Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP) adopted a positive opinion on the Orphan Medicinal Product…...
Radiation Supercharges Natural Killer Cell Therapy Against Liver Cancer in
6+ day, 12+ hour ago (830+ words) New Study Bioengineer.org...